News|Articles|April 24, 2025

Phage Therapy’s Future: Tackling Antimicrobial Resistance With Precision Viruses

Bacteriophage therapy presents a promising alternative to antibiotics, especially as antimicrobial resistance continues to increase. Dr. Ran Nir-Paz discusses its potential, challenges, and future applications in this technology.

As the global health community confronts the growing threat of antimicrobial resistance (AMR), researchers are turning to one of nature’s oldest bacterial enemies—bacteriophages. In this exclusive Q&A, Infection Control Today® (ICT®) speaks with Ran Nir-Paz, MD, an infectious diseases specialist at Hadassah Medical Organization in Jerusalem and a Professor of Microbiology and Medicine at the Department of Clinical Microbiology and Infectious Diseases at the Hadassah Hebrew University Medical Center.

Related to this article

Image of Pathogens flying   (Adobe Stock weerasak)
Behind every landmark in infection prevention, from antimicrobial stewardship guidelines to the COVID-19 town halls that reached flight attendants and teachers, is a generation of physician-scientists who led SHEA through crises, organizational change, and scientific breakthroughs. Infection Control Today traces 30 years of SHEA presidents and the lasting mark they left on the field.